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Abstract The chromatin structure is important for recog-
nition and repair of DNA damage. Many DNA damage
response proteins accumulate in large chromatin domains
flanking sites of DNA double-strand breaks. The assembly
of these structures—usually termed DNA damage foci—is
primarily regulated by MDC1, a large nuclear mediator/
adaptor protein that is composed of several distinct
structural and functional domains. Here, we are summariz-
ing the latest discoveries about the mechanisms by which
MDC1 mediates DNA damage foci formation, and we are
reviewing the considerable efforts taken to understand the
functional implication of these structures.
Introduction
The DNA, the genetic material of our cells, is constantly
exposed to DNA-damaging agents such as the sun’s
radiation or free oxygen radicals that arise as a consequence
of natural cellular metabolism. Alternatively, cells may
become transiently exposed to external sources of DNA
damage such as cigarette smoke or various toxic chemical
compounds. DNA double-strand breaks (DSBs), which are
a particularly deleterious form of DNA damage, are formed
upon treatment of the cells with ionizing radiation (IR) or
chemical clastogens. They are also formed in a programmed
manner during meiosis and development of the immune
system. Since DSBs are highly toxic lesions that can lead to
genomic rearrangements if they are not efficiently and
accurately repaired, it is not surprising that cells have
evolved highly sophisticated mechanisms to counteract
those threats. Based on a seminal Nature review article by
Zhou and Elledge in 2000, these mechanisms are often
referred to as the DNA damage response (DDR; Zhou and
Elledge 2000).
The DDR is a conglomerate of signaling transduction
pathways consisting of sensors, transducers, and effectors.
Although it is often delineated as a linear pathway, it is
more accurately described as a network of interacting
pathways that together execute the cellular response.
Components of the DDR in mammalian cells include the
phospho-inositide-like kinases (PIKKs) ATM, ATR, and
DNA-PKcs, the transducer kinases CHK1 and CHK2, and
the various effector proteins that are either targeted directly
by the PIKKs or by one or both of the transducer kinases.
Additional proteins have emerged as essential components
of the DDR eukaryotes. For example, there is a group of
proteins that contain phosphorylation-specific protein–pro-
tein interaction modules such as BRCA1 carboxy-terminal
(BRCT) domains and/or forkhead-associated (FHA)
domains. This protein family is usually referred to as
mediators/adaptors of the DDR because most of these
proteins lack enzymatic activity but may predominantly act
as “molecular matchmakers” through their ability to
mediate the efficient interaction of proteins that would
otherwise not bind to each other.
A major hallmark of the mammalian DDR is the rapid
deploying of a host of proteins to the sites of DNA damage
within the nuclei of affected cells. Some of these proteins
engage in the repair of the lesions, while others trigger
kinase-dependent signaling cascades that induce events not
only confined to the region where the damage has occurred,
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but involving the entire cellular system. Some of the DDR
factors that are rapidly recruited to sites of DNA damage
have intrinsic affinity to aberrant DNA structures. For
example, the MRE11/RAD50/NBS1 (MRN) complex, a
conserved DDR sensor and repair factor, has been shown to
bind preferentially to free DNA ends that arise at the sites
of DSBs (de Jager et al. 2001). Other factors do not just
bind to the DNA lesions per se, but accumulate in large
nuclear aggregates surrounding the lesion site. These
structures, which can be visualized by standard immuno-
fluorescence microscopy, are usually referred to as nuclear
foci, DNA damage foci, or ionizing radiation-induced foci
(IRIF). The key regulators of IRIF formation are histone
proteins that form the core of the nucleosome, the
organizational unit of eukaryotic genomes. In mammalian
cells, the histone H2A variant H2AX, a component of the
nucleosome core structure that comprises 10–15% of total
cellular H2A in higher organisms, is rapidly phosphorylated
by PIKKs on a conserved Ser residue at its C-terminus in
chromatin regions bearing DSBs. Phosphorylation of the
H2AX C-terminus (termed γH2AX) “spreads” over large
chromatin domains but is strictly confined to the damaged
chromosome and does not involve neighboring chromo-
somes that are not affected by DNA damage (Rogakou et
al. 1999). We are henceforth referring to these γH2AX
modified chromatin regions as γH2AX chromatin domains.
The phosphorylated H2AX C-terminus serves as an
epigenetic chromatin mark that flags regions in the genome
that contain DNA breaks. Mediator of the DNA damage
checkpoint 1 (MDC1; sometimes also referred to as
NFBD1), a large protein that belongs to the mediator/
adaptor group of DDR factors, specifically binds to the
phosphorylated H2AX C-terminus and appears to be the
predominant γH2AX recognition factor in mammalian
cells. MDC1 knockout mice display a very similar
phenotype as H2AX knockout mice, thus corroborating
the close functional relationship between these two DDR
factors (Table 1). Moreover, MDC1 is an emerging tumor
suppressor because loss of MDC1 is associated with
increased tumor frequency in mice (Minter-Dykhouse et
al. 2008), and reduction or lack of MDC1 is observed in a
significant proportion of carcinomas (Bartkova et al. 2007).
MDC1 is composed of several distinct domains and
regions. Each of these domains or regions seems to be
tailored to recognize one or several specific protein
interaction partners that are recruited to the damaged
chromatin regions.
In the past 5 years, we have seen much progress in the
exploration of the molecular mechanisms by which MDC1
recognizes the γH2AX chromatin mark and mediates the
interaction of several DDR factors with damaged chromatin
regions. Phosphorylation-dependent protein–protein inter-
actions that are dependent upon FHA and BRCT domains
appear to be the central theme of these processes. In this
article, we will review these latest findings. For the sake of
clarity, we decided to follow a structural delineation rather
than a chronological account by starting from the MDC1 C-
terminus and subsequently working our way up to the N-
terminus. We will briefly describe each of MDC1’s
structural and functional domains and regions and specify
the proteins that are binding to these domains and regions.
Moreover, we will summarize the functional implications of
each of these domains and regions, as far as they are
known. Finally, we will point out where our current
knowledge about MDC1 is still incomplete and we will
also highlight some of the major discrepancies in the
literature.
The C-terminal tandem BRCT domain: assembly
and maintenance of the γH2AX chromatin domain,
regulation of mitotic progression, and control
of the decatenation checkpoint
The tandem BRCT domain of MDC1 is located at the very
C-terminus of the protein, between amino acid 1891 and
2082 (Fig. 1). X-ray structural analysis revealed that this
region of MDC1 retains the typical tandem BRCT fold in
which each BRCT repeat adopts a compact α/β fold and is
connected by a linker region to form an extended structure
about 70 Å long and 35 Å in diameter (Lee et al. 2005;
Stucki et al. 2005). The first indication that the MDC1
tandem BRCT domain was involved in the regulation of the
assembly of the γH2AX chromatin domain came from the
observation that a green fluorescent protein (GFP) tagged
version of the protein lacking the C-terminal BRCT region
did not accumulate in IRIF in response to IR treatment.
Moreover, the same study showed that overexpression of
the BRCT region abrogated MDC1 and γH2AX IRIF
(Shang et al. 2003).
Since BRCT repeats can act as phosphopeptide-binding
domains, oriented phosphopeptide library screening was
used to define the optimal phosphopeptide binding motif
for the MDC1 BRCT tandem domain (Rodriguez et al.
2003; Stucki et al. 2005). These screens revealed that the
MDC1 tandem BRCT domain bound selectively to peptides
containing a phosphorylated Ser residue, and furthermore,
selected for Glu at the +2 position and Tyr at the +3
position after the phosphorylated serine. These binding
preferences closely match the sequence of the phosphory-
lated H2AX C-terminus (pS-Q-E-Y-COOH), suggesting
that γH2AX is one of the binding partners of the MDC1
tandem BRCT domain. Indeed, biochemical, X-ray struc-
tural, and cell biological approaches clearly demonstrated
that MDC1 directly interacts with γH2AX via its C-
terminal BRCT region (Lee et al. 2005; Lou et al. 2006;
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Stucki et al. 2005) (reviewed in Stucki and Jackson 2006).
The structural data revealed that the phospho-peptide
binding cleft of the MDC1 tandem BRCT domain is
exquisitely tailored to recognize the γH2AX motif (Lee et
al. 2005; Stucki et al. 2005). Point mutations in the
phosphopeptide binding cleft of the MDC1 BRCT tandem
domain, as well as in the H2AX C-terminus, abrogated the
MDC1–γH2AX interaction in vitro; disrupted IRIF forma-
tion by several DDR factors including MDC1 itself, the
MRN complex, phosphorylated ATM, 53BP1, and BRCA1;
and rendered cells radio-sensitive (Stucki and Jackson
2006). These findings strongly indicate that one of the
major biological functions of the MDC1 C-terminal BRCT
region is the initial recognition of the γH2AX chromatin
mark and the mediation of the recruitment and retention of
DDR factors in chromatin regions flanking DSBs.
MDC1 does not only recognize the γH2AX chromatin
mark, but it is also involved in its regulation. It was shown
that MDC1 loss or experimental disruption of the
MDC1–γH2AX interaction leads to reduced H2AX phos-
phorylation and small γH2AX IRIF (Lou et al. 2006;
Stewart et al. 2003; Stucki et al. 2005). This indicates that
MDC1 somehow positively regulates H2AX phosphoryla-
tion and that this regulation is dependent on the direct
interaction between MDC1 and γH2AX. Since H2AX
phosphorylation in response to DSBs does not spread in
three dimensions throughout the cell nucleus, but is
confined to chromatin regions flanking the break site on
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Fig. 1 Schematic representation of the domain architecture of MDC1
and its interaction partners. MDC1 is composed of several distinct
domains and regions that either interact with phosphorylated proteins
or are themselves phosphorylated and serve as docking sites for other
proteins that contain phospho-specific interaction modules such as
FHA and BRCT domains. Each of these domains and regions appears
to be functionally relevant for the DDR and/or for control of the cell
cycle. See text for details
Table 1 Phenotypes associated with MDC1 loss. MDC1 loss induces a multitude of phenotypes both on the cellular level and also on the level of
the whole organism
KO organism (mouse) KO cellular (mouse) siRNA cellular (human)
Small size Radiosensitivity Radiosensitivity
Male infertility Intra-S phase checkpoint Intra-S phase checkpoint
Radiosensitivity G2/M checkpoint G2/M checkpoint
Tumor-prone IRIF IRIF
Phosphorylation (CHK1, CHK2, ATM) Phosphorylation (CHK1, CHK2, ATM, SMC1)
DSB repair by HR DSB repair by HR
NHEJ of dysfunctional telomeres Random plasmid integration
Chromosomal instability Apoptosis
Reduced proliferation Slow mitosis
Class switch recombination
In this table we summarized the most important phenotypes associated with MDC1 loss
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the damaged chromosome (i.e. “spreads” only in two
dimensions), it was proposed that MDC1 may be required
for γH2AX spreading along the damaged chromatin fiber
(Lou et al. 2006; Stucki and Jackson 2006). According to
this model, MDC1 is recruited to γH2AX proximal to the
lesion and either directly or indirectly mediates the
recruitment and retention of activated ATM in the damaged
chromatin compartment. ATM could then phosphorylate
more H2AX molecules that are located more distal to the
initiating lesion. As a consequence, the γH2AX chromatin
mark would spread further and further away from the initial
break. However, the model of MDC1-fuelled self-reinforcing
H2AX phosphorylation cycles to spread the γH2AX chro-
matin mark along the chromosome axis has recently been
challenged. One of the major caveats in assessing the
mechanism of γH2AX formation was the lack of “resolu-
tion.” Up until recently, researchers have relied on micro-
scopic techniques to study the dynamic assembly of the
γH2AX chromatin domain. While these microscopic techni-
ques have been very useful to measure the kinetics of protein
recruitment to sites of DNA damage and to assess the
dynamics of the assembly and disassembly of the γH2AX
chromatin domain, they have not been capable of delivering
any information about the density of H2AX phosphorylation
and the distance of γH2AX spreading along the axis of the
damaged chromosome. However, there exists a very power-
ful technique that can yield this kind of data: chromatin
immunoprecipitation (ChIP). While ChIP has been widely
and successfully used to study the assembly of protein
complexes on chromatin, as well as the dynamic changes of
epigenetic states (e.g., in transcriptional control), its success-
ful application in the mammalian DDR field has long been
impeded by the challenge to efficiently induce DNA breaks at
specific loci in the genome. To circumvent this problem, one
group studied the spreading of γH2AX on shortened
telomeres in senescent primary cells (Meier et al. 2007).
Shortened telomeres in senescent cells have been shown to
trigger a DDR similar to the one that is activated by DSBs.
In this study, it was shown that the γH2AX chromatin mark
spreads up to about 570 kb into the subtelomeric regions.
Furthermore, the spreading pattern of MDC1 was very
similar to that of γH2AX, confirming the functional and
structural link between these two factors. Importantly, this
study also revealed that γH2AX density is not uniform
along the chromosome axis (Meier et al. 2007). Another
study recently used primary mouse lymphocytes to study
γH2AX density and spreading during V(D)J recombination
in G1 (Savic et al. 2009). The major advantage of this
experimental system is the efficiency by which the RAG1/
RAG2 (RAG) endonucleases induce DSBs between the
variable (V), diversity (D), and joining (J) gene segments
and their flanking RAG recognition sequences. Since the
genomic locations of the RAG-initiated DSBs are known,
γH2AX density and spreading could readily be measured
by ChIP at this specific locus. Surprisingly, these data
revealed that MDC1 is not required for the spreading of the
γH2AX chromatin mark but, instead, for keeping up a high
γH2AX density proximal to the break site (Savic et al.
2009). Thus, it is possible that the previously proposed
MDC1-dependent γH2AX self-reinforcing mechanism only
applies to chromatin regions close to the lesion, while other
mechanisms may regulate γH2AX spreading into more
distal regions of the damaged chromatin fiber. It remains to
be determined whether these observations only apply to
RAG-initiated DSBs or if they are a general characteristic of
the cellular response to DSBs.
It has been proposed that MDC1 may control H2AX
phosphorylation through another mechanism that is not
related to its ability to mediate the accumulation of active
ATM in damaged chromatin compartments. This model
suggests that MDC1 may control the dephosphorylation of
H2AX through its direct binding to the phospho-epitope
located at C-terminus of H2AX. This interpretation was
based on the observation that the purified MDC1 BRCT
domains could efficiently shield γH2AX phosphopeptides
from phosphatase activity in vitro. Moreover, overexpres-
sion of the isolated MDC1 BRCT region in mammalian
cells resulted in H2AX hyperphosphorylation (Stucki et al.
2005). It was recently discovered that the phosphatases
PP2A and PP4 are involved in the removal of γH2AX from
chromatin in mammalian cells (Nakada et al. 2008). Thus,
it will be interesting to see if MDC1 can limit the access of
these phosphatases to γH2AX in vivo.
The recent discovery of yet another phosphorylation
event at the H2AX C-terminus has added an additional
layer of complexity to the regulation of the γH2AX
chromatin domain. In two recent Nature articles, the Allis
and Rosenfeld laboratories described the phosphorylation
of Tyr142 (the very C-terminal amino acid of H2AX) by
the WICH complex and its dephosphorylation by the
EYA1/3 phosphatases (Cook et al. 2009; Xiao et al.
2009). As these findings and their implications for the
DDR have recently been reviewed in detail elsewhere
(Stucki 2009), we will just briefly summarize the main
issues here: while H2AX Ser139 is targeted by DNA
damage-activated PIKKs, Tyr142 is phosphorylated by the
constitutive kinase WSTF, a subunit of the WICH chroma-
tin remodeling complex. However, upon induction of DNA
damage, Tyr142 becomes dephosphorylated by the EYA1/3
phosphatases. How exactly this dephosphorylation is
regulated remains elusive, but Tyr142 dephosphorylation
is necessary for the assembly of the γH2AX chromatin
domain because MDC1 is not capable of efficiently binding
to γH2AX as long as Tyr142 is phosphorylated.
But what is the physiological role of H2AX Tyr142
phosphorylation? One attractive possibility is that the
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Tyr142 phosphorylation/dephosphorylation equilibrium
may determine cell fate in response to genotoxic stress.
As mentioned above, Tyr142 phosphorylation attenuates
MDC1 recruitment and the establishment of the γH2AX
chromatin domain. However, it was proposed that the
Tyr142 modification may promote the recruitment of the
pro-apoptotic factor JNK1 to sites of DNA damage (Cook
et al. 2009). Thus, if repair is possible, Tyr142 is
dephosphorylated and the DDR machinery is recruited to
sites of DNA damage to promote repair. However, if the
damage is too severe to be repaired in time, tyrosine
phosphorylation remains and apoptosis is favored through
the association of JNK1 with γH2AX. This is still a rather
simplified model, and our understanding of the regulation
of the γH2AX chromatin domain is still incomplete. Thus,
more work is needed to understand this important process
in detail.
Recently, two additional phosphorylation-specific inter-
action partners for the MDC1 BRCT domains have been
discovered. CDC27, a subunit of the anaphase promoting
complex APC/C was shown to interact directly with MDC1
via its phosphorylated C-terminal region (Coster et al.
2007). The APC/C is a multi-subunit E3 ubiquitin ligase
that controls mitotic progression mainly through ubiquitin-
dependent destruction of mitotic cyclins and other sub-
strates in a coordinated manner. Interestingly, the sequence
of the phosphorylated MDC1 binding site in CDC27 is
located at the very C-terminus of the protein and is very
similar to the MDC1 binding site in H2AX: the phospho-
acceptor Ser residue is also followed by a Glu at the +2
position and a Phe at the +3 position (pS-D-E-F-COOH).
Phosphopeptide screening has indicated that the MDC1
BRCT domains strongly select for Glu at +2, and Tyr, but
not Phe, at the +3 position (Rodriguez et al. 2003; Stucki et
al. 2005). Thus, it appears that CDC27 binding to MDC1 is
effectively produced by the strong selection of Glu at +2.
Moreover, the relative localization of the C-terminal
carboxylate in respect to the phosphorylated Ser residue is
identical in CDC27 and γH2AX. The kinase that targets the
CDC27 C-terminus is currently unknown, but considering
that the MDC1 CDC27 interaction is increased after DNA
damage (Coster et al. 2007), CDC27 phosphorylation may
be somehow modulated by DNA damage. An interesting
possibility would be that MDC1 is involved in the
regulation of mitotic progression in response to DNA
damage through its interaction with the APC/C. However,
no experimental evidence for such a function has yet been
produced. Instead, it was recently demonstrated that MDC1
is regulating mitotic progression independently of DNA
damage. Grant Stewart and colleagues showed that MDC1-
deficient human cells have defects in mitotic progression at
the metaphase/anaphase transition (Townsend et al. 2009).
Moreover, the activity of the APC/C ubiquitin ligase is
compromised in the absence of MDC1. However, mecha-
nistically, MDC1 appears to modulate the APC/C activity
rather through its interaction with CDC20 (an activator
protein that regulates the substrate specificity of the APC/C
ubiquitin ligase) and not through its interaction with the
APC/C subunit CDC27 (Townsend et al. 2009). Thus, it
remains elusive as to how the phospho-dependent MDC1–
CDC27 interaction contributes to the control of mitotic
progression.
Another phospho-specific MDC1 BRCT-interacting fac-
tor was recently discovered by Lou and colleagues: DNA
topoisomerase IIα (Topo IIα; (Luo et al. 2009)). MDC1-
Topo IIα interaction seems to regulate the decatenation
checkpoint, a checkpoint that controls the entanglement
(“catenation”) of chromosomes at the end of DNA
replication. This checkpoint arrests cells in G2 and delays
onset of mitosis until sister chromatids are fully separated.
A phosphorylation site close to the C-terminus of Topo IIα
appears to mediate the interaction with the MDC1 C-
terminal BRCT repeat. Surprisingly though, this phosphor-
ylation site presents only limited sequence similarity to the
H2AX and CDC27 C-terminal MDC1-binding epitopes,
suggesting a different mode of binding, or perhaps an
indirect interaction. Quantitative phosphopeptide-binding
studies and/or structural approaches will be required to
resolve this issue.
The PST repeat region: regulation of DSB repair
and mitotic progression?
The region in human MDC1 between amino acids 1141 and
1662 is generally referred to as the proline–serine–threo-
nine (PST)-rich repeat (Fig. 1). In humans, this region
consists of 13 consecutive imperfect repeats of 41 amino
acids. The PST repeat is one of the least conserved regions
in MDC1 and does not appear to exist at all in MDC1
orthologues of non-vertebrates (e.g.,Drosophila (Dronamraju
and Mason 2009)). However, in most vertebrate species, the
PST repeat is present and conserved, even though the
number of repeats varies greatly from 13 consecutive repeats
in human MDC1 to seven repeats in mouse MDC1. Primary
sequence analysis did not reveal any known structural and
functional motifs, and sequence comparison and database
searches did not retrieve significant homology to any other
known protein.
To this day, little is known about the functional
implication of the PST repeat region. However, it is clear
that the PST repeat is neither required for MDC1
accumulation at sites of DSBs (Shang et al. 2003), nor for
MDC1’s function to mediate the accumulation of 53BP1,
BRCA1, and the MRN complex in damaged chromatin
compartments (Lou et al. 2004; Xie et al. 2007) (see also
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next sections). In an early study by the Chen laboratory, it
was proposed that the PST repeat region constitutes a
binding site for DNA-PK. Moreover, in this work, it was
shown that deletion of the PST repeat triggers a partial non-
homologous end joining (NHEJ) defect (Lou et al. 2004).
However, the mechanism by which the MDC1 PST repeat
would regulate NHEJ remained elusive because MDC1 is
not required for DNA-PK recruitment to sites of DSBs
(Gottlieb and Jackson 1993). It was proposed that MDC1
may mediate the accumulation of DNA-PK in chromatin
regions flanking DSBs in similar manner as it mediates the
accumulation of the MRN complex (Lou et al. 2004).
However, DNA-PK does not seem to accumulate in IRIF in
response to DSBs (Bekker-Jensen et al. 2006). Thus, a
functional implication of the observed interaction between
the MDC1 PST region and DNA-PK remains elusive.
Interestingly, the PST repeat region does not only appear
to be important for DSB repair by NHEJ, but also for
homologous recombination (HR). In a genetic HR reporter
system, a mutant MDC1 version lacking the PST repeat
region was defective for HR, while this mutant was still
proficient in accumulating at sites of DSBs and in
mediating the accumulation of other DDR proteins such
as 53BP1, BRCA1 at sites of DSBs (Xie et al. 2007). It thus
appears that the MDC1 PST repeat region is implicated in
DSB repair by both NHEJ and HR, although the mecha-
nism of action of this unusual repeat motif in DSB repair
remains to be elucidated.
According to a recent report, the PST repeat region is
also implicated in mitotic progression. As outlined in the
last section, MDC1 deficient cells have defects in mitotic
progression at the metaphase/anaphase transition, which is
associated with an increased number of mitotic cells in a
population of MDC1 deficient cells as compared to control
cells that express normal amounts of MDC1 (Townsend et
al. 2009). Expression of a mutant MDC1 version lacking
the PST repeat region could not restore this mitotic defect
while expression of wild-type MDC1 rescued the pheno-
type. Interestingly, there seems to be an interaction between
several subunits of the APC/C and the MDC1 PST repeat
region, which may mechanistically explain the mitotic
defect observed in cells expressing a MDC1 version lacking
the PST repeat (Townsend et al. 2009).
The TQXF cluster: Regulation of chromatin
ubiquitylation
N-terminal of the PST repeat resides a region in MDC1 that
is characterized by a noticeable abundance of PIKK
consensus phosphorylation Ser/Thr-Gln (S/TQ) sites. Par-
ticularly striking is a cluster of four nearby TQ motifs that
are all followed by the Phe at the +3 position (located
between amino acid 699–768 in human MDC1). We will
henceforth refer to this region as the TQXF cluster. Early
studies on human MDC1 suggested that the protein is
targeted by ATM in response to IR treatment, but the exact
location of the phosphorylation sites were not determined
(reviewed in Stucki and Jackson 2004). However, at least a
subset of the TQXF motifs in MDC1 have recently been
identified to represent bona fide ATM targets in response to
IR (Kolas et al. 2007; Mailand et al. 2007; Matsuoka et al.
2007). Phosphorylation of these sites mediates the recruit-
ment of the E3 ubiquitin ligase RNF8 through direct
interaction of its FHA domain with the MDC1 phosphor-
ylated TQXF region (Huen et al. 2007; Kolas et al. 2007;
Mailand et al. 2007) (see Fig. 2). FHA domains, like BRCT
tandem domains, recognize amino acid sequences around a
central phosphorylation site. However, while BRCT tandem
domains recognize both pSer and pThr-containing sequen-
ces, FHA domains appear to only recognize pThr-containing
motifs (Durocher and Jackson 2002). Intriguingly, the RNF8
FHA domain showed strong selection for Phe and Tyr at
the +3 position (Huen et al. 2007). Such a selection for
aromatic amino acids at the +3 position closely resembles
the optimal phosphopeptide motifs recognized by the
tandem BRCT domains of MDC1 and BRCA1 (reviewed
in Mohammad and Yaffe 2009; see also above).
Immunofluorescence microscopy showed that deletion
of these TQXF motifs in MDC1 or depletion of RNF8 led
to impaired IRIF formation for conjugated ubiquitin, 53BP1
and BRCA1, whereas γH2AX, MDC1, and NBS1 IRIF
were not affected. Furthermore, 53BP1 and BRCA1
accumulation was dependent on the E3 ubiquitin ligase
domain (a RING domain) of RNF8, indicating that IRIF
formation of these proteins is controlled by local ubiquity-
lation of substrates in chromatin regions flanking DSBs.
Although the identity of these substrates has currently not
yet been addressed in vivo, several lines of in vitro
evidence suggest that the major RNF8 substrates that
mediate 53BP1 and BRCA1 accumulation at sites of DSBs
may be the histone proteins H2A and H2AX (Huen et al.
2007; Mailand et al. 2007).
What is the physiological role of local chromatin
ubiquitylation and how exactly does this posttranslational
modification influence the accumulation of DDR proteins
such as 53BP1 and BRCA1 in damaged chromatin regions?
Downregulation of RNF8 by small interfering RNAs
(siRNAs) yields a G2/M checkpoint defect and renders
cells radiosensitive, implicating MDC1-dependent local
chromatin ubiquitylation in DNA damage signaling and
perhaps also DSB repair in mammalian cells. The mecha-
nism, by which MDC1-dependent RNF8 recruitment
ensues the chromatin ubiquitylation cascade and mediates
IRIF formation by 53BP1 and BRCA1 appears to be rather
complicated and has yet to be resolved in detail. However,
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it is clear that at least one additional ubiquitin ligase and
ubiquitin-dependent adaptor proteins are involved in these
processes. As these downstream events are not directly
controlled by MDC1 and have been recently reviewed in
detail elsewhere (Panier and Durocher 2009; Van Attikum
and Gasser 2009), we will just briefly summarize the most
important findings here and outline the current model (see
Fig. 2).
While it was shown that the ubiquitin ligase activity of
RNF8 is required to trigger DSB-associated ubiquitylation,
it is not sufficient to sustain the conjugated ubiquitin in the
damaged chromatin regions. Several groups identified
RNF168 as a novel chromatin-associated ubiquitin ligase
that acts in concert with UBC13 to catalyze formation of
K63-linked ubiquitin conjugates and ubiquitylates family
members of the H2A family in regions surrounding the
DSB as efficiently as RNF8. In addition, RNF168 pos-
sesses the ability to bind ubiquitylated H2A in an RNF8-
dependent manner (Doil et al. 2009; Stewart et al. 2009).
This suggests that, while RNF8 acts as initiating ubiquitin
ligase in DSB-flanking chromatin, RNF168 activity stabil-
izes and/or amplifies the signal in order to reach a threshold
level that mediates the recruitment of downstream factors
53BP1 and BRCA1 and thereby allows the completion of
the DSB-induced chromatin response. Significantly,
RNF168 is mutated in RIDDLE syndrome patients that
Fig. 2 Model of the assembly of the γH2AX chromatin domain. 1 In
response to DSB-causing genotoxic agents MRN directly binds to free
DNA ends and facilitates the recruitment and activation of the ATM
kinase, which is autophosphorylated and, thus, converted from an
inactive dimer into active monomers. ATM phosphorylates H2AX in
the nearby DSB-flanking chromatin. 2 MDC1 recognizes the γH2AX
chromatin mark and mediates the sustained interaction of the MRN
complex with damaged chromatin through direct phosphorylation-
dependent interaction. 3 Phosphorylated MDC1 recruits the ubiquitin
ligase RNF8 and additional DDR factors, thereby triggering a
signaling cascade that is dependent on ubiquitylation of histones and
results in checkpoint activation and DNA repair. See text for details
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suffer from immunodeficiency and radiosensitivity (Stewart
et al. 2007, 2009). These phenotypes may arise mainly
from defective chromatin ubiquitylation and dysfunctional
53BP1 and BRCA1 retention, a process that may be
particularly important for the proper repair of programmed
DSBs during the development the immune system in
humans (recently reviewed in Stewart 2009).
The ubiquitylated histones likewise form a direct
recognition motif for the ubiquitin-interacting motif
(UIM)-containing receptor-associated protein 80 (RAP80),
leading to its accumulation in IRIF with a preference for
K63- and K6-linked ubiquitin polymers (Kim et al. 2007;
Sobhian et al. 2007; Wang et al. 2007). RAP80 accumulates
in IRIF and facilitates the recruitment of BRCA1, which is
mediated by Abraxas that directly interacts with the BRCT
domain of BRCA1 in a DNA damage-induced phospho-
dependent manner (Wang et al. 2007) (Fig. 2). Taken
together, the sequential recruitment of the three ubiquitin
ligases RNF8, RNF168, and BRCA1 and the resulting
ubiquitylation of chromatin components (perhaps mainly
H2A-type histones) imply that this type of posttranslational
modification represents a crucial novel regulatory process
in the response to genotoxic lesions.
While the MDC1/RNF8-dependent retention of BRCA1
can be mechanistically explained with a model that
involves direct protein–protein interactions, the MDC1/
RNF8-dependent accumulation of 53BP1 is less well
understood. No ubiquitin-binding domains have yet been
identified in 53BP1 that could explain its recruitment to
DSB-associated ubiquitylated chromatin components. Thus,
MDC1 may exert its function also more indirectly, e.g.,
through initiation of chromatin reorganization events that
would eventually increase the accessibility of proteins to
newly exposed histone marks that are buried in higher-
order chromatin structure. In this regard, the 53BP1 Tudor
domain was shown to be required for 53BP1 accumulation
at sites of DSBs (Huyen et al. 2004). These domains may
bind to methylated histone marks that are masked in
unperturbed chromatin, but may become locally exposed in
a ubiquitin-dependent manner in response to DNA damage
(Botuyan et al. 2006; Huyen et al. 2004). In any case, the
vast majority of data presently available promote the idea
that MDC1-mediated chromatin modifications and/or higher-
order chromatin rearrangements might facilitate the accumu-
lation and sustained retention of 53BP1 at sites of DSBs.
What is the functional implication of MDC1/RNF8-
mediated BRCA1 and 53BP1 accumulation at sites of
DSBs? While this is still not yet resolved in detail, an
interesting clue recently came from the telomere field. It
has been known for quite some time that chromosomes that
have lost their protective telomeric “cap” undergo chromo-
some end-to-end fusions in a process that is dependent on
the NHEJ machinery. MDC1-deficient cells show a
significant reduction in NHEJ of dysfunctional telomeres
(Dimitrova and de Lange 2006). This is most likely due to
the inefficient accumulation of 53BP1 at dysfunctional
telomeres in the absence of MDC1. 53BP1 is thought to
promote chromosome end-to-end fusions by altering the
dynamic behavior of chromatin at dysfunctional telomeres
(Dimitrova and de Lange 2008). However, it is not yet
known if this effect is specific for NHEJ of dysfunctional
telomeres or if it also applies to NHEJ in general.
The SDT repeat region: constitutive interaction
with the MRN complex
Upstream of the TQXF cluster, MDC1 features a second
repeat region that is characterized by conserved patches of
8–10 amino acids comprising Ser and Thr residues typically
separated by an aspartate and further embedded in an acidic
sequence environment. This so called SDT region (in some
papers also referred to as SDTD region) interacts with the
MRN complex in a phosphorylation-dependent manner
(Chapman and Jackson 2008; Melander et al. 2008;
Spycher et al. 2008; Wu et al. 2008) (Fig. 2). The MRN
complex is an essential component of the DNA damage
signaling machinery. Due to its ability to recognize free
DNA ends, the MRN complex is capable of acting as a
sensor of DSB. It further exhibits DNA-end processing
activity, tethers DNA ends, and is required for efficient
ATM kinase activation (reviewed in Williams et al. 2007).
Accomplishing the aforementioned functions does not seem
to require the presence of MDC1. However, similar to
53BP1 and BRCA1 (see above), accumulation and reten-
tion of MRN complex in DSB-flanking chromatin regions
strictly depends on MDC1 (Bekker-Jensen et al. 2006;
Goldberg et al. 2003; Lukas et al. 2004).
In human MDC1, six SDT motifs were identified, and
deletion of at least five of them leads to complete
abrogation of MRN IRIF formation (Melander et al. 2008;
Spycher et al. 2008). Analysis of NBS1 recruitment to sites
of DSBs revealed that, upon expression of an MDC1
version lacking the SDT regions, NBS1 only accumulates
in micro-IRIF but is not found in the broader chromatin
compartments usually covered by γH2AX and MDC1
(Chapman and Jackson 2008). This indicates that the
MRN complex is recruited to DSBs in a MDC1-
independent manner, but its sustained interaction with the
DSB-flanking chromatin requires MDC1.
Interestingly, MDC1 and MRN exist in a complex even
in undamaged cells. This interaction is dependent on the
activity of the acidophilic caseine kinase 2 (CK2) for which
the SDT motifs form consensus phosphorylation sites
(Spycher et al. 2008; Wu et al. 2008). Both Ser and Thr
residues in each SDT motif are phosphorylated by CK2 in
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vivo, and only doubly phosphorylated pSDpT motifs are
capable of mediating the interaction with NBS1 (Melander
et al. 2008; Spycher et al. 2008).
Two recent X-ray structural studies revealed that NBS1
contains a compact module at its N-terminus formed by an
FHA and a tandem BRCT domain (Lloyd et al. 2009;
Williams et al. 2009). Phosphopeptide-binding studies
revealed that both the FHA domain of NBS1 and its BRCT
domains preferentially bind to SDT-like motifs that are
phosphorylated on both Ser and Thr residues (Lloyd et al.
2009). These motifs are found in MDC1 (see above), and
also in fission yeast Ctp1 (the yeast orthologue of
mammalian CtIP that is involved in DSB resection and
HR) and budding yeast Lif1 (the yeast orthologue of
mammalian XRCC4 that is involved in NHEJ). Both Ctp1
and Lif1 have been shown to interact with the N-terminal
region of yeast NBS1 (Lloyd et al. 2009; Matsuzaki et al.
2008; Williams et al. 2009). MDC1 orthologues have so far
not been detected in yeast. It is currently also not known if
human NBS1 is capable of interacting with the human
orthologues of yeast Ctp1 and Lif1 (CtIP and XRCC4,
respectively) in a CK2-dependent manner.
Doubly phosphorylated pSDpTD peptides interact with
both FHA and BRCT domains of human NBS1 since only
mutations in both domains effectively abolished the
interaction (Lloyd et al. 2009). Mutation of key residues
in the FHA and the tandem BRCT domain similarly reduce
the interaction between CK2-phosphorylated MDC1 pro-
tein and the MRN complex, thus indicating the requirement
of an intact domain structure at the N-terminus of NBS1 for
optimal binding (Chapman and Jackson 2008; Lloyd et al.
2009). Moreover, alterations in either FHA or BRCT
domains impair relocalization of the MRN complex to
IRIF (Cerosaletti and Concannon 2003; Spycher et al.
2008; Wu et al. 2008; Xu et al. 2008). These data point to a
dual phospho-dependent interaction mode between MDC1
and the FHA/BRCT region of NBS1.
Functionally, the NBS1 FHA/BRCT region is required
for the activation of the intra-S-phase and the G2/M DNA
damage checkpoints and is likely also participating in DSB
repair. However, the molecular mechanisms underlying
these functional implications remain largely elusive. De-
fective checkpoint activation has been observed in NBS1
FHA and BRCT phospho-binding mutants (Difilippantonio
et al. 2007; Wu et al. 2008; Zhao et al. 2002), strongly
suggesting that the interaction with MDC1 may be required
for ensuing an efficient DNA damage checkpoint response.
However, it is not yet clear how exactly MDC1–NBS1
complex formation is implicated in DNA damage signaling.
One possibility is that accumulation and retention of the
MRN complex in chromatin regions flanking DSBs may
help to amplify the checkpoint response in the presence of
low numbers of DNA breaks (Spycher et al. 2008; Stucki
and Jackson 2006). In addition, MDC1-dependent chroma-
tin retention of NBS1 may also be necessary to efficiently
recruit the ATM kinase to the damaged chromatin compart-
ments (Falck et al. 2005), even though this issue is
currently still a matter of controversy (see also below).
The N-terminal FHA domain: an enigma at the end
Perhaps with the exception of the PST repeat region, the N-
terminal FHA domain of MDC1 is still the most enigmatic
element of this large and versatile mediator protein. This is
surprising given that FHA domains are well-characterized
phospho-specific interaction modules that occur rather
frequently in DDR proteins. It has also been clear for a
while that the N-terminal FHA domain is important for
MDC1’s functions in the DDR: deletion of this domain
leads to multiple DDR defects, including a defective G2/M
DNA damage checkpoint, inefficient DSB repair by sister
chromatid recombination, and reduced apoptosis in re-
sponse to IR (Lou et al. 2003, 2006; Xie et al. 2007; Zhang
et al. 2005). Even though several interaction partners for the
FHA domain have been identified in the past years, none of
them seems to quite “fit in.”
As a first candidate, phosphorylated CHK2 was de-
scribed as putative MDC1–FHA interacting factor (Lou et
al. 2003). Immunoprecipitation and peptide-binding studies
suggested that CHK2, phosphorlyated on Thr68, could
form a stable complex with MDC1 in vitro and in cell
extracts. Moreover, the MDC1 FHA domain was required
for this interaction. In support of this finding, oriented
phosphopeptide library screening revealed that the MDC1
FHA domain bound selectively to peptides containing a
phosphorylated Thr residue, and furthermore, selected for
Gln at the +1 position and Leu/Ile at the +3 position after
the phosphorylated Thr (Durocher et al. 2000). These
binding preferences closely match the sequence surround-
ing the Thr68 of CHK2 (pT-Q-E-L), thus corroborating the
interpretation that CHK2 phosphorylated on Thr68 is a
bona fide binding partner of the MDC1 FHA domain.
However, CHK2 and MDC1 do not co-localize in cells that
have been treated by DSB-inducing agents. While MDC1
accumulates in IRIF, CHK2 remains dispersed throughout
the nucleus (Lukas et al. 2003). This implies that the
interaction between MDC1 and phosphorylated CHK2 is
very transient in nature (at least in vivo) and, thus, does not
compare, for example, to the stable interaction between the
phosphorylated MDC1 TQXF cluster and the RNF8 FHA
domain, even though this latter interaction is also based on
a phosphorylated TQ motif and an FHA domain. Further-
more, it was recently shown that a tight pThr68-dependent
head-to-tail dimerization of CHK2 results in effective
occlusion of the phospho-epitope and would prevent
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interaction of the phospho-Thr68 motif with the MDC1
FHA domain (Li et al. 2008). However, autophosphoryla-
tion of CHK2 releases monomeric CHK2 (Ahn and Prives
2002; Li et al. 2008), which would expose the phospho-
Thr68 motif and, potentially, allow binding to the MDC1
FHA domain. This mechanism could cause a very rapid
switching of the phosphorylated CHK2 between MDC1-
bound state and MDC1-free dimeric state and may account
for the observation that, in response to DNA damage,
CHK2 remains dispersed throughout the nucleus and does
not accumulate in IRIF (Lukas et al. 2003).
MDC1 was also reported to interact with the ATM
kinase through its N-terminal FHA domain (Lou et al.
2006). Immunoprecipitation experiments showed that ATM
and MDC1 exist in a complex (Stewart et al. 2003).
Moreover, ATM seems to weakly associate with the
isolated FHA domain of MDC1 in vitro (Lou et al. 2006).
Immunofluorescence microscopy revealed that, in the
absence of MDC1 (or in the presence of an MDC1 version
lacking the N-terminal FHA domain), antibodies raised
against the autophosphorylated ATM kinase could not
anymore detect phospho-ATM IRIF accumulation, indicat-
ing that MDC1 may recruit phosphorylated ATM into
damaged chromatin compartments via direct interaction
with its FHA domain. However, it should be pointed out
that a correct interpretation of these data is difficult because
it is currently very difficult to control the specificity of
phospho-specific ATM antibodies in indirect immunofluo-
rescence. Phospho-specific antibodies raised against pTQ/
pSQ peptides are notoriously promiscuous and usually
cross-react with many PIKK target proteins (Matsuoka et
al. 2007). It is therefore likely that phospho-specific ATM
antibodies are no exception and may be recognizing other
proteins besides ATM in immunofluorescence. Thus, it is
not yet clear if ATM IRIF formation is really dependent on
the MDC1 FHA domain. To complicate matters further, it
has also been suggested that ATM accumulation at sites of
DSBs is mediated by the C-terminal region of NBS1. ATM
IRIF formation was defective in cells expressing a NBS1
version lacking a C-terminal ATM-interacting peptide
(Falck et al. 2005). Since NBS1 IRIF formation is also
dependent on MDC1, it is possible that ATM accumulation
is not mediated by direct interaction with MDC1, but
indirectly, through its association with the NBS1 C-
terminus. To resolve this matter in an unbiased manner,
ATM IRIF formation needs to be analyzed with antibodies
raised against the non-phosphorylated protein, whose
specificity can be properly controlled in ATM-deficient
cells. Alternatively, GFP-tagged recombinant ATM may be
used to test if IRIF accumulation is dependent upon the
SDT region of MDC1 (that mediates the accumulation of
the MRN complex, see above), or upon the FHA domain of
MDC1 that may directly interact with ATM.
The MDC1 FHA domain has also been implicated in
DSB repair via sister chromatid recombination (Xie et al.
2007; Zhang et al. 2005). It was proposed that this is
brought about through a specific interaction between the
FHA domain of MDC1 and the recombinase RAD51
(Zhang et al. 2005). However, this is difficult to compre-
hend because, at early time points after irradiation, RAD51
foci and MDC1 IRIF do not co-localize (Goldberg et al.
2003). Moreover, RAD51 and MDC1 do not occupy the
same compartments at sites of DSBs: while RAD51 binds
to single-stranded DNA stretches that are the result of DSB
resection in S and G2 phases of the cell cycle, MDC1
accumulates in the chromatin compartment flanking sites of
DSBs, independently of the cell cycle state (Bekker-Jensen
et al. 2006). Thus, whether and how interaction between the
MDC1 FHA domain and RAD51 contributes to DSB repair
by HR remains elusive.
Concluding remarks
In the past few years, MDC1 has emerged as a prototype
mediator, acting mainly as a “molecular matchmaker” in the
mammalian response to DNA damage. The entire protein
appears to be composed of regions and domains that are
involved in protein–protein interactions; most of them
occur as phosphorylation-specific interactions.
Recent key findings have also significantly contributed
to our understanding as to how MDC1 functions in the
DDR. The best-characterized functional role of this protein
is that it acts as a bridging element to dynamically tether
various DDR factors to damaged chromatin regions that
contain phosphorylated H2AX molecules. Mechanistically,
this function is based upon a very specific interaction
between the MDC1 C-terminal tandem BRCT domain and
the phosphorylated H2AX C-terminus. Moreover, several
domains and regions within the central and N-terminal
sections of MDC1 feature repeated sequence motifs that are
shaped by post-translational modifications, mostly phos-
phorylations. These regions are then recognized by proteins
that contain domains capable of specifically binding to the
modified amino acid stretches such as FHA and BRCT
tandem domains. These factors subsequently accumulate at
sites of DSBs and, thus, the γH2AX chromatin domain is
efficiently established.
While the mechanism of accumulation of DDR factors in
damaged chromatin and the role of MDC1 in this process is
now relatively well understood, it is much more difficult to
implicate these processes to the physiological roles of
MDC1. While we do know that MDC1 is important for the
activation of the intra-S phase and G2/M DNA damage
checkpoint and for DSB repair, it is not clear yet how
exactly these physiological roles are connected to MDC1’s
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major task to control the assembly of the γH2AX
chromatin domain. This is especially true for checkpoint
activation. To make this point clear, we touch on just one
example: As outlined above, MDC1 is implicated in the
G2/M DNA damage checkpoint. Theoretically, this func-
tion could be mediated by 53BP1 or BRCA1 accumulation
because both 53BP1 and BRCA1 are implicated in the G2/
M checkpoint response and mutation of the TQXF cluster
of MDC1 that is essential for 53BP1 and BRCA1
accumulation triggers a G2/M checkpoint defect. However,
deletion of the MDC1 FHA domain also triggers a G2/M
checkpoint defect, which might be related to the ability of
the FHA domain to interact with ATM and CHK2, factors
that are also critical to induce a proper G2/M checkpoint
response. To complicate matters further, MDC1 also
mediates the accumulation of the MRN complex via direct
interaction of its phosphorylated SDT repeats with the
FHA/BRCT region of NBS1. Mutation in the FHA domain
of NBS1 also results in a G2/M checkpoint defect,
indicating that MDC1-mediated accumulation of NBS1 in
damaged chromatin regions may be required for proper G2/
M checkpoint activation. The relative contribution of these
protein–protein interactions is not yet clear and no firm
mechanistic explanation is yet available as to how MDC1-
mediated accumulation of DDR factors at sites of DSBs
brings about an efficient G2/M checkpoint response.
Thus, while MDC1 has clearly emerged as the major
organizer of the assembly and maintenance of the γH2AX
chromatin domain, we still need to learn a lot more about
how these events translate into a timely and efficient DDR
that protects cells from the deleterious and dangerous
effects of DNA damage and chromosomal instability.
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